Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

C21 Investments Announces Q2 Earnings Date and Provides Operational Update
New Dispensary Generating Strong Sales Growth during the Quarter Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, today announced its expected date for reporting its second quarter financial results for the period ended September 30, 2024. The Company is also taking the opportunity to provide an operational update for the period.» Mehr auf newsfilecorp.com
C21 Investments Provides MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). As previously announced on May 31, 2024 (the "Announcement"), the Company applied for a management cease trade order ("MCTO") from the British Columbia Securities Commission (the "BCSC") due to an expected delay in filing of the audited consolidated financial statements for the year ended January 31, 2024 (the "Annual Financial Statements"), annual management's discussion and analysis for the same period and management certifications of annual filings (collectively, the "Annual Filings") beyond the deadline of May 31, 2024 prescribed by Canadian securities laws.» Mehr auf newsfilecorp.com
C21 Investments Provides MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - July 12, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). As previously announced on May 31, 2024 (the "Announcement"), the Company applied for a management cease trade order ("MCTO") from the British Columbia Securities Commission (the "BCSC") due to an expected delay in filing of the audited consolidated financial statements for the year ended January 31, 2024 (the "Annual Financial Statements"), annual management's discussion and analysis for the same period and management certifications of annual filings (collectively, the "Annual Filings") beyond the deadline of May 31, 2024 prescribed by Canadian securities laws.» Mehr auf newsfilecorp.com

Unternehmenszahlen

Im letzten Quartal hatte C21 INVESTMENTS INC. Aktie einen Umsatz von 7,60 Mio€ und ein Nettoeinkommen von −125,89k€

(EUR)	Dez. 2024	YOY
Umsatz	+7,60 Mio	-
Bruttoeinkommen	+3,49 Mio	-
Nettoeinkommen	−125,89k	-
EBITDA	+1,41 Mio	-

Fundamentaldaten

Metrik	Wert
Marktkapitalisierung	+16,87 Mio€
Anzahl Aktien	117,86 Mio
52 Wochen-Hoch/Tief	+0,27€ - +0,10€
Dividenden	Nein
Beta	2,46
KGV (PE Ratio)	−4,79
KGWV (PEG Ratio)	−0,76
KBV (PB Ratio)	+0,70
KUV (PS Ratio)	+0,73

Unternehmensprofil

C21 Investments Inc. ist ein integriertes Cannabisunternehmen, das in den Vereinigten Staaten Cannabis- und Hanfprodukte anbaut, verarbeitet, vertreibt und vermarktet. Es bietet verpackte und Großhandelsblüten, Verdampferstifte, gehärtete Extrakte, Esswaren, Pre-Rolls, Tinkturen und topische Produkte an. Das Unternehmen war früher als Curlew Lake Resources Inc. bekannt und änderte im November 2017 seinen Namen in C21 Investments Inc. um. C21 Investments Inc. wurde 1987 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.